Literature DB >> 2169498

Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.

D R Carrigan1, K K Knox, M A Tapper.   

Abstract

The pathogenesis of AIDS is complex and poorly understood despite intensive research efforts. One of the most puzzling aspects of the disease is the long interval between primary infection with human immunodeficiency virus (HIV) and the production of antiviral antibodies and onset of overt disease. Probably the most important factor that determines the length of these intervals is the rate at which HIV replicates within the infected host. Molecular studies have suggested that the replication of HIV can be enhanced by concurrent infection with other viruses, especially herpesviruses such as cytomegalovirus, herpes simplex virus, and Epstein-Barr virus. Presumably the presence of those viruses would serve to accelerate the progression of HIV-mediated disease. In contrast, studies reported here indicate that coinfection of cell populations with HIV and human herpesvirus-6 (HHV-6) leads to a near total suppression of HIV replication. The replication of HHV-6 is unaffected or minimally enhanced by the presence of HIV. These findings suggest that HHV-6 might serve to slow the progression of disease in some HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169498     DOI: 10.1093/infdis/162.4.844

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors:  H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 4.  CXCR4: a virus's best friend?

Authors:  Kathleen L Arnolds; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2014-05-02       Impact factor: 3.342

5.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

Authors:  Z N Berneman; D V Ablashi; G Li; M Eger-Fletcher; M S Reitz; C L Hung; I Brus; A L Komaroff; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses.

Authors:  V Koval; C Clark; M Vaishnav; S A Spector; D H Spector
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes.

Authors:  S F Josephs; D V Ablashi; S Z Salahuddin; L L Jagodzinski; F Wong-Staal; R C Gallo
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Structure and heterogeneity of the a sequences of human herpesvirus 6 strain variants U1102 and Z29 and identification of human telomeric repeat sequences at the genomic termini.

Authors:  B J Thomson; S Dewhurst; D Gray
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.